Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Search
Medicines Law & Policy
Research and resources on intellectual property and health
Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Tag: WTO
WTO Covid-19 TRIPS Decision: Some observations
Medicines Law & Policy
-
June 17, 2022
Proposed TRIPS waiver a hollow diplomatic compromise with little practical impact
Medicines Law & Policy
-
April 12, 2022
Wrapping up 2021 – some noteworthy medicines law and policy events
Ellen 't Hoen
-
December 24, 2021
Landmark decision by the World Health Assembly to start negotiations for...
Kaitlin Mara
-
December 1, 2021
Imagine if health and trade ministers would meet in one room...
Ellen 't Hoen
-
November 30, 2021
The EU proposed Covid waivers of certain TRIPS rules are mostly...
Medicines Law & Policy
-
October 14, 2021
Ensuring that intellectual property rights aren’t a barrier to scaling-up: the...
Medicines Law & Policy
-
April 13, 2021
Wrapping up 2020 with some noteworthy medicines, law and policy events
Medicines Law & Policy
-
December 29, 2020
Decision on intellectual property waiver over Covid technology on hold till...
Kaitlin Mara
-
December 18, 2020
What is the ‘know-how gap’ problem and how might it impact...
Christopher Garrison
-
December 16, 2020
1
2
3
Page 1 of 3
This work is licensed under Creative Commons.